WallStreetZenWallStreetZen

NASDAQ: TSHA
Taysha Gene Therapies Inc Stock Ownership - Who owns Taysha Gene Therapies?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Taysha Gene Therapies Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul B. Manning10% Owner2025-05-30750,000$2.75
$2.06MBuy
Kamran AlamCHIEF FINANCIAL OFFICER2025-03-1129,843$1.69
$50.43kSell
Paul B. Manning10% Owner2024-06-271,333,333$2.25
$3.00MBuy

1 of 1

TSHA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TSHA insiders and whales buy or sell their stock.

TSHA Shareholders

What type of owners hold Taysha Gene Therapies Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Avoro Capital Advisors LLC9.32%19,999,999$50.80MInstitution
Rtw Investments LP8.75%18,787,866$47.72MInstitution
Morgan Stanley7.85%16,846,374$42.79MInstitution
Fmr LLC7.28%15,631,954$39.71MInstitution
Blackrock Inc6.33%13,589,178$34.52MInstitution
Ra Capital Management LP5.06%10,872,503$27.62MInstitution
Octagon Capital Advisors LP4.98%10,700,000$27.18MInstitution
Ra Session Ii4.20%9,012,837$22.89MInsider
Vanguard Group Inc4.09%8,770,921$22.28MInstitution
Audentes Therapeutics Inc3.39%7,266,342$18.46MInsider

1 of 3

TSHA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TSHA77.69%14.30%Net BuyingNet Buying
MRVI45.33%54.67%Net SellingNet Selling
MNMD47.83%52.17%Net SellingNet Selling
VERV63.99%36.01%Net BuyingNet Selling
KROS73.36%26.64%Net BuyingNet Buying
View Top Biotech Stocks

Taysha Gene Therapies Stock Ownership FAQ

Who owns Taysha Gene Therapies?

Taysha Gene Therapies (NASDAQ: TSHA) is owned by 77.69% institutional shareholders, 14.30% Taysha Gene Therapies insiders, and 8.02% retail investors. Ra Session Ii is the largest individual Taysha Gene Therapies shareholder, owning 9.01M shares representing 4.20% of the company. Ra Session Ii's Taysha Gene Therapies shares are currently valued at $22.89M.

If you're new to stock investing, here's how to buy Taysha Gene Therapies stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.